Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Apr 17;17(1):141.
doi: 10.1186/s13256-023-03891-4.

Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report

Cyrille Donfo-Azafack  1 , Hugues C Nana-Djeunga  1 , Guy Wafeu-Sadeu  1 , Raïssa Dongmo-Yemele  1 , Joseph Kamgno  2   3
Affiliations
Case Reports

Successful management of poisoning with ivermectin (Mectizan) in the Obala health district (Centre Region, Cameroon): a case report

Cyrille Donfo-Azafack et al. J Med Case Rep. .

Abstract

Background: Ivermectin (Mectizan) is an anthelmintic drug that plays a major role in the fight against two major filarial diseases, onchocerciasis and lymphatic filariasis. Unlike previous drugs that had serious and sometimes fatal side effects, ivermectin has been considered to be safe and, therefore, is widely used. Data reporting the clinical presentation of poisoning with ivermectin are very scanty, even in experimental studies.

Case presentation: In this paper, we report the case of a 19-year-old Black African female student residing in Obala (Centre Region, Cameroon) who was admitted to a health facility in Central Cameroon for a neurological disorder after intoxication with about 400 tablets of ivermectin 3 mg (~100 times the standard doses). This neurological disorder was characterized by somnolence, kinetic ataxia, increase of tendon reflex, and central visual disturbance. Management of this intoxication consisted of symptomatic treatment and monitoring of hemodynamic parameters for 5 days, with a favorable course.

Conclusions: This is the first report of a poisoning with ivermectin at ~100 times the recommended dose. This case report confirms the safety and tolerability of ivermectin, even at exceptionally high dose.

Keywords: Cameroon; Case report; Ivermectin; Mectizan; Obala district hospital; Poisoning.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Campbell WC, Fisher MH, Stapley EO, Albers-Schonberg G, Jacob TA. Ivermectin: a potent new antiparasitic agent. Science. 1983;221:823–828. doi: 10.1126/science.6308762. - DOI - PubMed
    1. Develoux M. Ivermectine. Ann Dermatol Venereol. 2004;131:561–570. doi: 10.1016/S0151-9638(04)93668-X. - DOI - PubMed
    1. Geary TG. Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol. 2005;21(11):530–532. doi: 10.1016/j.pt.2005.08.014. - DOI - PubMed
    1. Boatin BA, Hougard JM, Alley ES, Akpoboua LK, Yameogo L, Dembele N, Seketeli A, Dadzie KY. The impact of Mectizan on the transmission of onchocerciasis. Ann Trop Med Parasitol. 1998;92(Suppl 1):S46–60. - PubMed
    1. Aziz MA, Diallo S, Lariviere M, Diop IM, Porta IM, Gaxotte P. Ivermectin in onchocerciasis. Lancet. 1982;2(8313):1456–1457. doi: 10.1016/S0140-6736(82)91350-2. - DOI - PubMed

Publication types